More on XFOR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-283.3% Growth)
- Ratings (9.1 Score)

Upcoming Events

- Earnings (3/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

X4 Pharmaceuticals (NQ:XFOR)
Delayed: 3.76 +0.06 (1.62%)
Prev. Close $3.70  
Open$3.65 
52 Wk High$ 
52 Wk Low$ 
Day High$3.86 
Day Low$3.65 
P/E N/A  
EPS$ 
Volume282,180 

Friends, Peers and Foes (?): ABP, CPIX ALT (more...)

Mar 6, 2026 04:24 PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: MORGAN STANLEY
Mar 4, 2026 07:00 AM X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
Mar 2, 2026 04:30 PM X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 27, 2026 07:03 AM X4 Pharmaceuticals receives EU committee recommendation for WHIM drug
Feb 27, 2026 07:00 AM X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
Feb 17, 2026 04:33 PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 17, 2026 04:32 PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Trails Edge Capital Partners, LP
Feb 17, 2026 04:31 PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Bain Capital Life Sciences Fund, L.P.
Feb 17, 2026 02:47 PM Form SCHEDULE 13G X4 Pharmaceuticals, Inc Filed by: Saturn V Capital Management LP
Feb 13, 2026 05:10 PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: Nantahala Capital Management, LLC
View All Articles

Entities mentioned with XFOR

View All Entities